Zacks Investment Research
12 Mar 2026, 22:30 UTC · 27w ago
Verdict
Headline takes no side. We score SKIN +0.40 across three claims — moderately bullish.
+0.40moderately bullish
More positive than 63% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
The Beauty Health Company (SKIN) reported quarterly revenue of $82.4 million, beating the Zacks Consensus Estimate of $78.17 million by 5.42%.
More positive than 50% of claims this week
The Beauty Health Company (SKIN) saw a 1.3% year-over-year decline in revenue for the quarter ended December 2025.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 71% of claims this week
The Beauty Health Company (SKIN) reported an EPS of -$0.06, which outperformed the consensus estimate of -$0.07 by 7.69%.
More positive than 45% of claims this week
Which stocks this story touches
More positive than 63% of ticker scores this week
The company beat both revenue and EPS consensus estimates, despite a slight year-over-year revenue decline.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−36.2%
Price is moving against the score
$0.6767 vs $1.06 close before publication (Mar 12) · not market-adjusted
SKIN chart →
